Immediate Impact
2 from Science/Nature 64 standout
Citing Papers
The Cation−π Interaction in Chemistry and Biology
2025 Standout
Deuterium in drug discovery: progress, opportunities and challenges
2023 Standout
Works of G. Greim being referenced
Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration
2002
Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors. European Organization for Research and Treatment of Cancer Early Clinical Studies Group.
2000
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| G. Greim | 256 | 106 | 18 | 100 | 8 | 422 | |
| J-L Fischel | 253 | 171 | 31 | 128 | 13 | 510 | |
| Femke M. de Man | 233 | 213 | 18 | 91 | 18 | 507 | |
| Lynn Adams | 206 | 80 | 8 | 93 | 9 | 372 | |
| Rui Bras-Gonçalves | 235 | 201 | 13 | 101 | 12 | 480 | |
| Laura Milesi | 246 | 126 | 8 | 87 | 16 | 445 | |
| Wayne D. Brenckman | 148 | 143 | 35 | 71 | 15 | 438 | |
| Linda D. Compton | 254 | 223 | 10 | 48 | 11 | 478 | |
| J. H. M. Schellens | 278 | 155 | 27 | 79 | 18 | 491 | |
| Binyan Lin | 240 | 173 | 13 | 140 | 9 | 440 | |
| S P Khor | 248 | 103 | 19 | 77 | 10 | 414 |
All Works
Loading papers...